Table 1 Drug use indicators derived from questionnaire
From: Access to artemisinin combination therapy for malaria in remote areas of Cambodia
Objective of malaria drug policy | Indicator |
|---|---|
Increase treatment from trained provider | % of people with fever who went to a trained provider |
Increase use of biological diagnosis | % of people with fever who had a biological diagnosis |
Reduce delay in treatment | % of people who receive modern drugs within 48 hours of symptoms |
Correct drug choice | % of first-line drug (artesunate and mefloquine) as proportion of modern drugs |
Decrease use of artemisinin monotherapy | % of artemisinin monotherapy as a proportion of all artemisinin use |
Adherence to ACT | % of people who take artesunate and mefloquine for at least 3 days |
Reduce patient costs | Median drug cost of treatment |